The Vascular Effects of Exenatide Versus Metformin in Patients With Pre-Diabetes
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effects of exenatide versus metformin on vascular
health with chronic (3-month) therapy and during a 2-hour period following a meal in patients
with pre-diabetes. It is predicted that exenatide will improve vascular health to a greater
degree compared to metformin.
Phase:
Phase 4
Details
Lead Sponsor:
St. Paul Heart Clinic
Collaborators:
Amylin Pharmaceuticals, LLC. Eli Lilly and Company International Diabetes Center at Park Nicollet